感覚受容体を除くGPCRをヒト 300種、マウス 250種、計550種取り揃え、共役するGαタンパク質のサブタイプに依らず単一フォーマットのアッセイで活性を評価します。 各受容体の詳細は表をクリックしてください。また、ラット、ウサギ、イヌ、カニクイザルなど他種のGPCRについてはお問い合わせください。
Filters Sort results
Reset Apply
Species | Receptor | Family | Assays | |
|---|---|---|---|---|
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: LH‐RH EC50: 200 pM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: histamine EC50: 61 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: histamine EC50: 150 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: histamine EC50: 240 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: histamine EC50: 110 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: kisspeptin‐10 EC50: 4.2 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: LTB4 EC50: 100 pM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: LTB4 EC50: | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: LTD4 EC50: 16 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: LTD4 EC50: 1.0 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: CH3‐carbamyl PAF C‐16 EC50: 480 pM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: EC50: 350 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: EC50: | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: EC50: | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: EC50: | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: LPA‐Na EC50: | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: S1P EC50: 100 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: S1P EC50: 100 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: EC50: 17 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: S1P EC50: 100 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: MCH EC50: 36 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: α‐MSH EC50: 3.2 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: ACTH EC50: 27 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: α‐MSH EC50: 370 pM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: α‐MSH EC50: 5.2 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: α‐MSH EC50: 19 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: melatonin EC50: 110 pM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: melatonin EC50: 230 pM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: L‐glutamic acid EC50: 5.5 µM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: L‐glutamic acid EC50: 6.9 µM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: L‐glutamic acid EC50: 15 µM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: L‐glutamic acid EC50: 74 µM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: L‐glutamic acid EC50: 18 µM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: NMU‐23 EC50: 2.2 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: NMU‐23 EC50: 350 pM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: NPFF EC50: 7.2 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: NPFF EC50: 120 pM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: NPW‐30 EC50: 61 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: NPY EC50: 1.2 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: NPY EC50: 4.6 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: NPY EC50: 62 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: NPY EC50: 14 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: neurotensin EC50: 74 pM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: SR48692 EC50: 13 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: Leu‐enkephalin EC50: 3.3 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: dynorphin A EC50: 8.3 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: DAMGO EC50: 27 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: nociceptin EC50: 1.3 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: orexin A EC50: 1.8 nM | ||
Mouse | Available Assay modes: Agonist ⋅ Inverse agonist ⋅ Antagonist ⋅ PAM ⋅ NAM Panels: Mouse non-orphan GPCRs ⋅ à la carte |  Reference agonist: orexin A EC50: 7.8 nM |
お問い合わせ
試験委託、見積依頼、共同研究のご提案、その他お問い合わせを賜ります。まずはアッセイ系について説明を受けたい、どのような試験デザインが可能か検討したい、といったご要望に応え、電話やウェブ会議での無料相談も行っています。以下のフォームかメールにてご連絡下さい。
試験委託の流れ
見積り依頼
ご希望、目的に適した試験と価格をご提案します。
STEP
1
発注
試験受委託契約を締結して頂きます。秘密保持契約も可能です。
STEP
2
化合物送付
当社宛に化合物をお送り頂きます。
STEP
3
報告書受領
試験開始から通常3週間後に結果報告書と生データを電子メールでお送りします。
STEP
4